News Conference News ESC 2016 Platelet Function Testing to Guide Treatment Does Not Benefit Elderly ACS Patients: ANTARCTIC Todd Neale August 28, 2016
News Daily News Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI Michael O'Riordan August 24, 2016
News Daily News Data Gap: Best Strategy Unknown for A-Fib Patients on Newer Anticoagulants Who Need PCI L.A. McKeown August 17, 2016
Presentation ACC 2016 Optimal Loading Dose and Delivery of P2Y12 Inhibitors: Should the Loading Dose Be Crushed? Presenter: Dominick Angiolillo April 03, 2016
News Daily News Crushed Prasugrel Pills Beat Whole Tablets for Controlling Platelets During Primary PCI Caitlin E. Cox March 28, 2016
News Opinion Editor's Corner ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More Shelley Wood March 28, 2016
News Daily News Medication Adherence Suffers With Delayed Follow-up After Acute MI Todd Neale March 24, 2016
News Daily News Calculator Estimates Spontaneous MI Risk in Medically Managed NSTE ACS Patients Todd Neale March 16, 2016
Presentation JIM 2016 Oral antiplatelet therapy in elderly New P2Y12 inhibitors are the right choice Presenter: Alberto Menozzi February 11, 2016
Presentation JIM 2016 Intravenous P2Y12 Receptor Inhibitors With Powerful Oral Antiplatelets Are The New Best Option! Presenter: Roxana Mehran February 11, 2016
News Daily News Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI L.A. McKeown February 09, 2016
News Opinion Conversations in Cardiology Conversations in Cardiology: Post-PCI Clopidogrel in CHAMPION PHOENIX Trial of Cangrelor February 08, 2016
News Daily News Interhospital Transfer for Acute MI Associated With Disruptions in Aftercare, More Readmissions L.A. McKeown January 27, 2016
News Daily News Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS Shelley Wood January 21, 2016
News Daily News Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128 Caitlin E. Cox December 20, 2015
News Daily News Prometedores Primeros Datos para el Fármaco Antiplaquetario Reversible de Acción Rápida PZ-128 Caitlin E. Cox December 20, 2015
News Daily News Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines Yael L. Maxwell December 14, 2015
News Daily News Según un Análisis los Beneficios Hemorrágico de la Bivalirudina Disminuyen a medida que Avanza la PCI Todd Neale December 14, 2015
News Daily News Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows Todd Neale December 14, 2015
News Daily News Many Lower-Income Patients Fail to Stick With Clopidogrel After PCI Todd Neale December 10, 2015